Rate My Professor Hilman Harryanto

Dr. Harryanto's clinical expertise spans general respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, and interstitial lung disease, with a subspecialty focus on thoracic oncology, pulmonary nodule assessment, complex airway diseases, and lung cancer management. He specializes in the rapid assessment, investigation, and surveillance of suspected lung cancer, as well as procedural interventions for pulmonary complications including malignant pleural effusions and haemoptysis. His procedural skills include endobronchial ultrasound (EBUS) bronchoscopy, navigational bronchoscopy, and pleuroscopy. He contributes to multidisciplinary care pathways and continuing medical education, developing teaching resources for healthcare professionals. His research specializations encompass pulmonary medicine, interventional pulmonology, thoracic diseases, airway obstruction, malignant pleural effusions, and lung diseases. Notable publications include 'The Steroid Therapy and Outcome of Parapneumonic Pleural Effusions (STOPPE): A Pilot Randomized Trial' (2022), 'Transbronchial Lung Cryobiopsy: A Meticulous Technique' (2020), 'Multi-focal, multi-centric granular cell tumours: a management dilemma' (2018), 'End-of-life care of oncology inpatients: Are we getting it right?' (2018), 'A high COPD assessment test score may predict anxiety in COPD' (2018), 'Clinical features and long-term outcome of patients with saddle pulmonary embolism' (2019), 'A rare case of intraluminal pulmonary artery small cell lung carcinoma mimicking an intravascular thrombus' (2019), and 'Acquired hypertrichosis lanuginosa: A case of paraneoplastic excessive hair growth in lung cancer' (2019).